Background: Cerebral venous thrombosis (CVT) is a rare but severely disabling form of stroke. Acute treatment mainly consists of medical management, since there is no robust evidence suggesting the benefit of endovascular treatment for CVT. Given the relative lack of data to guide acute treatment decision-making, CVT treatment decisions are mostly made on a case-by-case basis. In some ways, the current status quo of endovascular treatment for CVT resembles the state of endovascular treatment for acute ischemic stroke before the wave of major positive large vessel occlusion endovascular treatment trials in 2015. Summary: The current state of evidence with regard to endovascular CVT treatment is summarized, parallels to acute ischemic stroke are drawn, and it is discussed how the lessons learned from the evolution of acute ischemic stroke endovascular treatment (EVT) trials could be applied to designing a trial of endovascular treatment for CVT. The review ends by outlining possible scenarios for the future of endovascular CVT treatment. Key Messages: CVT is a serious disease, affecting young patients and their families, and harbors a considerable social and economic burden. Working toward high-level evidence for the best possible treatment strategy and exploring a possible role for EVT to improve outcomes in CVT needs to remain a high priority in stroke research.

1.
Goyal
M
,
Menon
BK
,
van Zwam
WH
,
Dippel
DW
,
Mitchell
PJ
,
Demchuk
AM
, et al
.
Endovascular thrombectomy after large-vessel ischaemic stroke: a meta-analysis of individual patient data from five randomised trials
.
Lancet
.
2016
;
387
(
10029
):
1723
31
.
2.
Broderick
JP
,
Palesch
YY
,
Demchuk
AM
,
Yeatts
SD
,
Khatri
P
,
Hill
MD
, et al
.
Endovascular therapy after intravenous t-PA versus t-PA alone for stroke
.
N Engl J Med
.
2013
;
368
(
10
):
893
903
.
3.
Ciccone
A
,
Valvassori
L
,
Nichelatti
M
,
Sgoifo
A
,
Ponzio
M
,
Sterzi
R
, et al
.
Endovascular treatment for acute ischemic stroke
.
N Engl J Med
.
2013
;
368
(
10
):
904
13
.
4.
Kidwell
CS
,
Jahan
R
,
Gornbein
J
,
Alger
JR
,
Nenov
V
,
Ajani
Z
, et al
.
A trial of imaging selection and endovascular treatment for ischemic stroke
.
N Engl J Med
.
2013
;
368
(
10
):
914
23
.
5.
Coutinho
JM
,
Zuurbier
SM
,
Bousser
MG
,
Ji
X
,
Canhao
P
,
Roos
YB
, et al
.
Effect of endovascular treatment with medical management vs standard care on severe cerebral venous thrombosis: the TO-ACT randomized clinical trial
.
JAMA Neurol
.
2020
;
77
(
8
):
966
73
.
6.
Afifi
K
,
Bellanger
G
,
Buyck
PJ
,
Zuurbier
SM
,
Esperon
CG
,
Barboza
MA
, et al
.
Features of intracranial hemorrhage in cerebral venous thrombosis
.
J Neurol
.
2020
;
267
(
11
):
3292
8
.
7.
Coutinho
JM
,
Ferro
JM
,
Zuurbier
SM
,
Mink
MS
,
Canhão
P
,
Crassard
I
, et al
.
Thrombolysis or anticoagulation for cerebral venous thrombosis: rationale and design of the TO-ACT trial
.
Int J Stroke
.
2013
;
8
(
2
):
135
40
.
8.
Aguiar de Sousa
D
,
Lucas Neto
L
,
Arauz
A
,
Sousa
AL
,
Gabriel
D
,
Correia
M
, et al
.
Early recanalization in patients with cerebral venous thrombosis treated with anticoagulation
.
Stroke
.
2020
;
51
(
4
):
1174
81
.
9.
Aguiar de Sousa
D
,
Pereira-Santos
MC
,
Serra-Caetano
A
,
Neto
LL
,
Sousa
AL
,
Gabriel
D
, et al
.
Matrix metalloproteinase-9 levels are associated with brain lesion and persistent venous occlusion in patients with cerebral venous thrombosis
.
Thromb Haemost
.
2021
;
121
(
11
):
1476
82
.
10.
Siegler
JE
,
Shu
L
,
Yaghi
S
,
Salehi Omran
S
,
Elnazeir
M
,
Bakradze
E
, et al
.
Endovascular therapy for cerebral vein thrombosis: a propensity-matched analysis of anticoagulation in the treatment of cerebral venous thrombosis
.
Neurosurgery
.
2022
;
91
(
5
):
749
55
.
11.
Saposnik
G
,
Bushnell
C
,
Coutinho
JM
,
Field
TS
,
Furie
KL
,
Galadanci
N
, et al
.
Diagnosis and management of cerebral venous thrombosis: a scientific statement from the American heart association
.
Stroke
.
2024
;
55
(
3
):
e77
90
.
12.
Wahood
W
,
Rizvi
AA
,
Patel
V
,
Narain
S
,
Cloft
H
,
Rabinstein
AA
, et al
.
Trends in utilization and outcomes of mechanical thrombectomy for cerebral venous thrombosis: a National Inpatient Sample study
.
Interv Neuroradiol
.
2023
:
15910199231182454
.
13.
Martin
SS
,
Aday
AW
,
Almarzooq
ZI
,
Anderson
CAM
,
Arora
P
,
Avery
CL
, et al
.
2024 heart disease and stroke statistics: a report of US and global data from the American heart association
.
Circulation
.
2024
;
149
(
8
):
e347
913
.
14.
Zhou
LW
,
Yu
AYX
,
Ngo
L
,
Hill
MD
,
Field
TS
.
Incidence of cerebral venous thrombosis: a population-based study, systematic review, and meta-analysis
.
Stroke
.
2023
;
54
(
1
):
169
77
.
15.
Klein
P
,
Shu
L
,
Nguyen
TN
,
Siegler
JE
,
Omran
SS
,
Simpkins
AN
, et al
.
Outcome prediction in cerebral venous thrombosis: the IN-REvASC score
.
J Stroke
.
2022
;
24
(
3
):
404
16
.
16.
Koopman
K
,
Uyttenboogaart
M
,
Vroomen
PC
,
van der Meer
J
,
De Keyser
J
,
Luijckx
GJ
.
Development and validation of a predictive outcome score of cerebral venous thrombosis
.
J Neurol Sci
.
2009
;
276
(
1–2
):
66
8
.
17.
Bushnaq
SA
,
Qeadan
F
,
Thacker
T
,
Abbas
M
,
Carlson
AP
.
High-risk features of delayed clinical progression in cerebral venous thrombosis: a proposed prediction score for early intervention
.
Interv Neurol
.
2018
;
7
(
6
):
297
307
.
18.
Lindgren
E
,
Krzywicka
K
,
de Winter
MA
,
Sánchez Van Kammen
M
,
Heldner
MR
,
Hiltunen
S
, et al
.
A scoring tool to predict mortality and dependency after cerebral venous thrombosis
.
Eur J Neurol
.
2023
;
30
(
8
):
2305
14
.
19.
Jovin
TG
,
Li
C
,
Wu
L
,
Wu
C
,
Chen
J
,
Jiang
C
, et al
.
Trial of thrombectomy 6 to 24 hours after stroke due to basilar-artery occlusion
.
N Engl J Med
.
2022
;
387
(
15
):
1373
84
.
20.
Tao
C
,
Nogueira
RG
,
Zhu
Y
,
Sun
J
,
Han
H
,
Yuan
G
, et al
.
Trial of endovascular treatment of acute basilar-artery occlusion
.
N Engl J Med
.
2022
;
387
(
15
):
1361
72
.
21.
Li
Q
,
Abdalkader
M
,
Siegler
JE
,
Yaghi
S
,
Sarraj
A
,
Campbell
BCV
, et al
.
Mechanical thrombectomy for large ischemic stroke: a systematic review and meta-analysis
.
Neurology
.
2023
;
101
(
9
):
e922
32
.
22.
Leach
JL
,
Fortuna
RB
,
Jones
BV
,
Gaskill-Shipley
MF
.
Imaging of cerebral venous thrombosis: current techniques, spectrum of findings, and diagnostic pitfalls
.
Radiographics
.
2006
;
26
(
Suppl 1
):
S19
43
.
23.
Girot
M
,
Ferro
JM
,
Canhão
P
,
Stam
J
,
Bousser
MG
,
Barinagarrementeria
F
, et al
.
Predictors of outcome in patients with cerebral venous thrombosis and intracerebral hemorrhage
.
Stroke
.
2007
;
38
(
2
):
337
42
.
24.
Mehvari Habibabadi
J
,
Saadatnia
M
,
Tabrizi
N
.
Seizure in cerebral venous and sinus thrombosis
.
Epilepsia Open
.
2018
;
3
(
3
):
316
22
.
25.
Ferro
JM
,
Canhão
P
,
Stam
J
,
Bousser
M-G
,
Barinagarrementeria
F
,
ISCVT Investigators
.
Prognosis of cerebral vein and dural sinus thrombosis: results of the international study on cerebral vein and dural sinus thrombosis (ISCVT)
.
Stroke
.
2004
;
35
(
3
):
664
70
.
26.
Kim
DJ
,
Honig
A
,
Alimohammadi
A
,
Sepehry
AA
,
Zhou
LW
,
Field
TS
.
Recanalization and outcomes after cerebral venous thrombosis: a systematic review and meta-analysis
.
Res Pract Thromb Haemost
.
2023
;
7
(
3
):
100143
.
27.
Goyal
M
,
Fladt
J
,
Coutinho
JM
,
McDonough
R
,
Ospel
J
.
Endovascular treatment for cerebral venous thrombosis: current status, challenges, and opportunities
.
J Neurointerv Surg
.
2022
;
14
(
8
):
788
93
.
28.
Field
TS
,
Hill
MD
.
Cerebral venous thrombosis
.
Stroke
.
2019
;
50
(
6
):
1598
604
.
29.
Abdalkader
M
,
Finitsis
S
,
Li
C
,
Hu
W
,
Liu
X
,
Ji
X
, et al
.
Endovascular versus medical management of acute basilar artery occlusion: a systematic review and meta-analysis of the randomized controlled trials
.
J Stroke
.
2023
;
25
(
1
):
81
91
.
30.
Nguyen
TN
,
Qureshi
MM
,
Klein
P
,
Yamagami
H
,
Abdalkader
M
,
Mikulik
R
, et al
.
Global impact of the COVID-19 pandemic on cerebral venous thrombosis and mortality
.
J Stroke
.
2022
;
24
(
2
):
256
65
.
31.
Field
TS
,
Dizonno
V
,
Almekhlafi
MA
,
Bala
F
,
Alhabli
I
,
Wong
H
, et al
.
Study of rivaroxaban for cerebral venous thrombosis: a randomized controlled feasibility trial comparing anticoagulation with rivaroxaban to standard-of-care in symptomatic cerebral venous thrombosis
.
Stroke
.
2023
;
54
(
11
):
2724
36
.
32.
Redfors
B
,
Gregson
J
,
Crowley
A
,
McAndrew
T
,
Ben-Yehuda
O
,
Stone
GW
, et al
.
The win ratio approach for composite endpoints: practical guidance based on previous experience
.
Eur Heart J
.
2020
;
41
(
46
):
4391
9
.
33.
Goyal
M
,
Shamy
M
,
Menon
BK
,
Saver
JL
,
Diener
H-C
,
Mocco
J
, et al
.
Endovascular stroke trials: why we must enroll all eligible patients
.
Stroke
.
2013
;
44
(
12
):
3591
5
.
34.
Coutinho
JM
,
van de Munckhof
A
,
Aguiar de Sousa
D
,
Poli
S
,
Aaron
S
,
Arauz
A
, et al
.
Reducing the global burden of cerebral venous thrombosis: an international research agenda
.
Int J Stroke
.
2024
:
17474930241242266
.
You do not currently have access to this content.